A suspected case of Progressive Familial Intra-hepatic Cholestasis in a Six-Year-Old Nigerian Child
Progressive Familial Intra-hepatic Cholestasis (PFIC) is a group of heterogeneous, autosomal recessive disorders characterized by cholestasis, jaundice and mutilating pruritus, mostly in infancy. The incidence of PFIC ranges from 1:50,000 to 1:100,000. There are three subtypes; Types 1 and 2 typically present in the neonatal period and early infancy while Type 3 can present in early infancy, childhood or adolescence.
This report is about a 6-year old Nigerian girl who presented with jaundice and severe pruritus of one-month duration and abdominal pain of a week duration. The symptoms were preceded by ingestion of Atropine meant for ocular examination two days earlier. She was well-nourished, deeply icteric, had generalized healing scratch marks and hepatomegaly. The laboratory findings included conjugated hyperbilirubinaemia, moderately elevated liver transaminases and Gamma-Glutamyltransferase enzymes. She was managed for PFIC3 using oral ursodeoxycholic acid with complete resolution of the disease.
Gaur K, Sakhuja P. Progressive familial Intra-hepatic cholestasis: A comprehensive review of a challenging liver disease. Indian J Pathol Microbiol 2017; 60(1): 2–7.
Gunaydin M, BozkurterCil AT. Progressive familial Intra-hepatic cholestasis: diagnosis, management, and treatment. Hepat Med 2018; 10: 95–104. Available at https://doi.org/10.2147/HMER.S137209. Accessed on 30 July 2018.
Amer S, Hajira A. Comprehensive Review of Progressive Familial Intra-hepatic Cholestasis (PFIC): Genetic Disorders of Hepatocanalicular Transporters. Gastroenterol Res 2014; 7(2): 39–43. doi: [10.14740/gr609e. Accessed on 04 August 2018.
Lucena JF, Herrero JI, Quiroga J, Sangro B, Garcia-Foncillas J, Zabalegui N, Sola J, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003; 124(4): 1037–1042. doi: 10.1053/gast.2003.50144 Accessed on 04 August 2018.
Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Systematic review of progressive familial Intra-hepatic cholestasis. Clin Res Hepatol Gastroenterol 2019; 43(1): 20-36.
Ramraj R, Finegold MJ, Karpen SJ. Progressive familial Intra-hepatic cholestasis type-3 overlapping presentation with Wilson disease. Clin Pediatr (Phila) 2012; 51(7): 689-691.
Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448-1458.
Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial Intra-hepatic cholestasis. Orphanet J Rare Dis 2009; 4: 1. Available at https://doi.org/10.1186/1750-1172-4-1 Accessed on 10 September 2018.
Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol 2012; 4(2): 18–34.
Kurbegov AC, Setchell KD, Haas JE, Mierau GW, Narkewicz M, Bancroft JD, et al. Biliary diversion for progressive familial Intra-hepatic cholestasis: Improved liver morphology and bile acid profile. Gastroenterology 2003; 125: 1227-1234.
Copyright (c) 2019 Annals of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.